SNWV SANUWAVE Health, Inc.
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.…
Industry Peers
Medical DevicesKey Statistics
About SANUWAVE Health (NASDAQ: SNWV)
›
SANUWAVE Health (NASDAQ: SNWV) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 55 employees.
The shares were at 1.820 USD on 13 November 2026, down 94.5% over 52 weeks. Its 52-week range is 1.550 USD to 35.29 USD: the price is 94.8% below the high and 17.4% above the low.
Its market capitalisation is 15.66M USD.
SANUWAVE Health reports an operating margin of 1.3% and revenue down 25.1% year over year.
Its debt exceeds its cash by 13.04M USD, a debt-to-equity ratio of 14.19. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. The next earnings report is expected on 25 March 2027.